1 |
Water
| 1件: Water Water | 8件: AVONEX AVONEX; ENBREL; Hiberix; Indocyanine green; OMNITROPE; Sterile Water for Injection; Water; WATER FOR INJECTION; | - | - | 21件: 2 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299 |
2 |
Tretinoin
| 1件: Tretinoin Tretinoin | 5件: ATRA ATRA; Retinoic acid; Tretinoin; TRETINOINA; VESANOID; | 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 6件: 2 2, 62, 63, 75, 94, 231 |
3 |
Cyclosporine
| 1件: Cyclosporine Cyclosporine | 10件: Ciclosporin Ciclosporin; Ciclosporina; Ciclosporine; Cyclosporin; Cyclosporin A; Cyclosporine; Cyclosporine A; Ikervis; NEORAL; Restasis; | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
4 |
Acetylcysteine
| 1件: Acetylcysteine Acetylcysteine | 3件: Acetylcysteine Acetylcysteine; Mucomyst; N-acetylcysteine; | - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
5 |
Aminophylline
| 1件: Aminophylline Aminophylline | 1件: Aminophylline Aminophylline; | 18件: ADORA1 ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 63 63 |
6 |
Amoxicillin
| 1件: Amoxicillin Amoxicillin | 4件: Amoxicilina Amoxicilina; Amoxicillin; Amoxycillin; Augmentin; | - | - | 9件: 6 6, 19, 46, 63, 84, 96, 97, 222, 299 |
7 |
Azathioprine
| 1件: Azathioprine Azathioprine | 3件: Azathioprine Azathioprine; Azatioprina; Imuran; | - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
8 |
Clarithromycin
| 1件: Clarithromycin Clarithromycin | 1件: Clarithromycin Clarithromycin; | - | - | 8件: 6 6, 63, 84, 96, 97, 222, 228, 299 |
9 |
Danazol
| 1件: Danazol Danazol | 1件: Danazol Danazol; | 3件: AR AR, ESR1, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 60 60, 63, 64, 65, 285 |
10 |
Dexamethasone
| 1件: Dexamethasone Dexamethasone | 5件: Decadron Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
11 |
Lansoprazole
| 1件: Lansoprazole Lansoprazole | 1件: Lansoprazole Lansoprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 7件: 63 63, 71, 85, 98, 166, 222, 299 |
12 |
Methylprednisolone
| 1件: Methylprednisolone Methylprednisolone | 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
13 |
Metronidazole
| 1件: Metronidazole Metronidazole | 3件: Flagyl Flagyl; Metronidazol; Metronidazole; | - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 |
14 |
Prednisolone
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
15 |
Prednisone
| 1件: Prednisone Prednisone | 3件: Prednisona Prednisona; PREDNISONE; RAYOS; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
16 |
Pyrimethamine
| 1件: Pyrimethamine Pyrimethamine | 2件: Daraprim Daraprim; Pyrimethamine; | - | - | 12件: 2 2, 4, 6, 13, 19, 46, 51, 63, 65, 96, 97, 265 |
17 |
Sirolimus
| 1件: Sirolimus Sirolimus | 3件: Rapamune Rapamune; Rapamycin; Sirolimus; | 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 |
18 |
Alemtuzumab
| 1件: Alemtuzumab Alemtuzumab | 4件: Alemtuzumab Alemtuzumab; Campath; Lemtrada; MABCAMPATH; | 1件: CD52 CD52 💬 | - | 22件: 13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 |
19 |
Rituximab
| 1件: Rituximab Rituximab | 6件: MABTHERA MABTHERA; Rituxan; RITUXIMAB; Rixathon; Ruxience; TRUXIMA; | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
20 |
Belimumab
| 1件: Belimumab Belimumab | 2件: Belimumab Belimumab; BENLYSTA; | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 |
21 |
Bortezomib
| 1件: Bortezomib Bortezomib | 3件: Bortezomib Bortezomib; Bortezomib Accord; VELCADE; | 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 17件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 |
22 |
Decitabine
| 1件: Decitabine Decitabine | 1件: Decitabine Decitabine; | 3件: DNMT1 DNMT1, DNMT3A, DNMT3B 💬 | 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer 💬 | 3件: 13 13, 60, 63 |
23 |
Palmitic acid
| 1件: Palmitic Acid Palmitic Acid | 1件: Palmitate Palmitate; | - | - | 1件: 63 63 |
24 |
Toralizumab
| 1件: Toralizumab Toralizumab | 1件: Anti-CD40L Anti-CD40L; | 1件: CD40LG CD40LG 💬 | 14件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | 1件: 63 63 |
25 |
Natalizumab
| 1件: Natalizumab Natalizumab | 2件: Natalizumab Natalizumab; TYSABRI; | 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 6件: 13 13, 15, 25, 46, 63, 96 |
26 |
Diacerein
| 1件: Diacerein Diacerein | 1件: Diacerein Diacerein; | - | - | 3件: 36 36, 46, 63 |
27 |
Amoxicillin
| 1件: Amoxicillin Amoxicillin | 4件: Amoxicilina Amoxicilina; AMOXICILLIN; Amoxycillin; Augmentin; | - | - | 9件: 6 6, 19, 46, 63, 84, 96, 97, 222, 299 |
28 |
Atorvastatin
| 1件: Atorvastatin Atorvastatin | 3件: Atorvastatin Atorvastatin; Atorvastatin calcium; Lipitor; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 |
29 |
Hydroxychloroquine
| 1件: Hydroxychloroquine Hydroxychloroquine | 3件: Hydroxychloroquine Hydroxychloroquine; HYDROXYCHLOROQUINE SULFATE; Plaquenil; | - | - | 27件: 13 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 |
30 |
Montelukast
| 1件: Montelukast Montelukast | 3件: MONTELUKAST MONTELUKAST; MONTELUKAST SODIUM; Singulair; | 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 8件: 6 6, 13, 46, 61, 63, 85, 98, 228 |
31 |
Romiplostim
| 1件: Romiplostim Romiplostim | 2件: NPLATE NPLATE; ROMIPLOSTIM; | 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 4件: 60 60, 63, 64, 65 |
32 |
Avatrombopag
| 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag Avatrombopag; Doptelet; | 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 |
33 |
Blisibimod
| 1件: Blisibimod Blisibimod | 1件: Blisibimod Blisibimod; | - | - | 5件: 43 43, 44, 49, 63, 66 |
34 |
Daratumumab
| 1件: Daratumumab Daratumumab | 2件: Daratumumab Daratumumab; Darzalex; | 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 5件: 13 13, 28, 48, 49, 63 |
35 |
Zanubrutinib
| 1件: Zanubrutinib Zanubrutinib | 1件: Zanubrutinib Zanubrutinib; | 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 5件: 13 13, 63, 222, 300, 331 |
36 |
Vonoprazan
| 1件: Vonoprazan Vonoprazan | 1件: Vonoprazan Vonoprazan; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 63 63, 98 |
37 |
Efgartigimod alfa
| 1件: Efgartigimod alfa Efgartigimod alfa | 1件: Efgartigimod alfa Efgartigimod alfa; | 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 35, 53, 63, 162 |
38 |
Mezagitamab
| 1件: Mezagitamab Mezagitamab | 1件: Mezagitamab Mezagitamab; | 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 2件: 63 63, 66 |
39 |
Ianalumab
| 1件: Ianalumab Ianalumab | 1件: IANALUMAB IANALUMAB; | 1件: TNFRSF13C TNFRSF13C 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | 7件: 35 35, 46, 49, 53, 61, 63, 95 |
40 |
Orelabrutinib
| 1件: Orelabrutinib Orelabrutinib | 1件: Orelabrutinib Orelabrutinib; | 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 4件: 13 13, 49, 61, 63 |
41 |
Rozanolixizumab
| 1件: Rozanolixizumab Rozanolixizumab | 1件: ROZANOLIXIZUMAB ROZANOLIXIZUMAB; | 1件: FCGRT FCGRT 💬 | - | 3件: 11 11, 14, 63 |